**TB: Naija's Battle Against the Silent Killer** Nigeria, a country at the forefront of the global fight against tuberculosis (TB), is facing a daunting challenge. Donor contributions, a vital lifeline in the battle against TB, are dwindling. This has left Nigeria with a pressing concern: preventing looming drug shortages that could undo a decade of progress in the fight against this silent killer. TB, a disease that affects millions worldwide, claims thousands of lives in Nigeria each year. The country bears a significant burden of TB cases, which poses a serious threat to public health and the economy. In recent years, Nigeria has made significant strides in fighting TB, thanks to sustained efforts by government agencies, NGOs, and other stakeholders. However, the tide is turning. Donor contributions, which have been a significant source of funding for TB control efforts in Nigeria, are decreasing. This has left the country's healthcare system scrambling to find alternative sources of funding to keep the TB treatment program afloat. The consequences of a TB drug shortage would be dire. Thousands of Nigerians living with TB would be denied access to life-saving treatment, leading to a surge in mortality rates and a reversal of the progress made in the past decade. The economic implications would also be severe, as TB treatment is a significant expenditure for the Nigerian healthcare system. In response to this challenge, the Nigerian government is taking decisive action to prevent a TB drug shortage. The government is working with stakeholders to identify alternative funding sources, including local and international partnerships, to ensure that TB treatment programs continue to receive the necessary funding. Additionally, the government is also exploring innovative solutions to improve the efficiency of TB treatment programs and reduce costs. This includes leveraging technology to enhance case detection, improve treatment outcomes, and reduce the burden on healthcare workers. As Nigeria navigates this challenging period, one thing is clear: the fight against TB requires sustained commitment and resources. With the decline in donor contributions, it is more important than ever that Nigerians come together to support the country's TB control efforts. By working together, we can prevent a TB drug shortage and continue to make progress in the fight against this deadly disease. The Nigerian government's efforts to prevent a TB drug shortage are a testament to the country's commitment to public health and the well-being of its citizens.